Close Menu

23andMe Pledges QC

23andMe took to its blog, The Spittoon, yesterday to provide a public update on the recent sample switch-up at its contracted partner, LabCorp. The DTC firm confirms that "the processing mistake was caused by human error and the incorrect placement of a single 96-well plate used in processing samples." 23andMe writes that, along with their contracted laboratory, they are taking measures to prevent future mix-ups.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.